Bristol-Myers Squibb Co officer, Phil M Holzer, is set to sell 700 shares of the company's common stock on 11/04/2024, with an aggregate market value of $38,930.50. The shares to be sold were acquired through restricted stock vesting as part of compensation on two separate dates, 03/10/2023 and 03/10/2024, with the issuer being the source of the securities. This transaction follows a period where there were no reported sales of securities by Holzer in the past three months.

Bristol-Myers Squibb Co officer, Phil M Holzer, is set to sell 700 shares of the company's common stock on 11/04/2024, with an aggregate market value of $38,930.50. The shares to be sold were acquired through restricted stock vesting as part of compensation on two separate dates, 03/10/2023 and 03/10/2024, with the issuer being the source of the securities. This transaction follows a period where there were no reported sales of securities by Holzer in the past three months.